Schizoaffective Disorder News and Research

RSS
Impaired emotion recognition runs in families with psychosis

Impaired emotion recognition runs in families with psychosis

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Johnson & Johnson sales increase 9.1% to $19.5 billion in second quarter 2014

Maternal inflammatory marker linked to children’s schizophrenia risk

Maternal inflammatory marker linked to children’s schizophrenia risk

Brain structure linked to psychosis symptoms

Brain structure linked to psychosis symptoms

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Little efficacy difference between old and new antipsychotics

Little efficacy difference between old and new antipsychotics

Hippocampal role in psychosis bolstered

Hippocampal role in psychosis bolstered

Reduced rheumatoid arthritis risk in schizophrenia linked to underreporting

Reduced rheumatoid arthritis risk in schizophrenia linked to underreporting

Further support for hippocampal volume as psychosis biomarker

Further support for hippocampal volume as psychosis biomarker

Substance abuse worsens course of first-episode psychosis

Substance abuse worsens course of first-episode psychosis

Factors predicting disengagement from psychosis early intervention identified

Factors predicting disengagement from psychosis early intervention identified

‘Healthy living’ programme fails to lower BMI in overweight psychosis patients

‘Healthy living’ programme fails to lower BMI in overweight psychosis patients

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Cognitive therapy promising for patients who shun antipsychotics

Cognitive therapy promising for patients who shun antipsychotics

Substance use ‘dramatically’ high in severe psychosis

Substance use ‘dramatically’ high in severe psychosis

People with severe mental illness may have higher risk for substance use

People with severe mental illness may have higher risk for substance use

Negative symptoms and cognition ‘relatively independent’ in schizophrenia

Negative symptoms and cognition ‘relatively independent’ in schizophrenia

Resting-state connectivity and metabolism dissociated in schizophrenia

Resting-state connectivity and metabolism dissociated in schizophrenia

Rates of smoking, drinking and drug use are higher among people with psychotic disorders

Rates of smoking, drinking and drug use are higher among people with psychotic disorders

Brain network disruption crosses psychosis diagnostic boundaries

Brain network disruption crosses psychosis diagnostic boundaries